Get started
Author

Ernst Ulsperger

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial
2006 · Thomas Brodowicz, Maciej Krzakowski, et al. · Lung Cancer · 321
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
2015 · Luis Paz-Ares, Jörg Mezger, et al. · The Lancet Oncology · 135
The impact of extracellular matrix on the chemoresistance of solid tumors – experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy
1998 · G Baumgartner, Ch Gomar-Höss, et al. · Cancer Letters · 123
Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance
2017 · Lukas Klameth, Barbara Rath, et al. · Scientific Reports · 87
PDF
Randomized phase II study of three doses of the integrin inhibitor cilengitide versus docetaxel as second-line treatment for patients with advanced non-small-cell lung cancer
2012 · Christian Manegold, Johan Vansteenkiste, et al. · Investigational New Drugs · 64
PDF
Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers
2006 · Martina Müller, Martina Meyer, et al. · International Journal of Oncology · 59
PDF
Surgery For Cure Followed By Chemotherapy In Small Cell Carcinoma Of The Lung: For The Isc-Lung Cancer Study Group
1995 · Karl Karrer, Ernst Ulsperger · Acta Oncologica · 49
PDF
In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines
2011 · Wolfgang Fiebiger, Ulrike Olszewski, et al. · Clinical & Translational Oncology · 44
A review of the role of surgery for small cell lung cancer and the potential prognostic value of enumeration of circulating tumor cells
2016 · G. Hamilton, B. Rath, et al. · European Journal of Surgical Oncology · 34
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent
2009 · Ulrike Olszewski, Florian Ach, et al. · Metal-Based Drugs · 34
PDF
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML)
2019 · Klaus Geissler, Eva Jäger, et al. · Wiener klinische Wochenschrift · 28
PDF
Multimodality treatment for small cell bronchial carcinoma *1, *2Preliminary results of a prospective, multicenter trial
1991 · E ULSPERGER, K KARRER, et al. · European Journal of Cardio-Thoracic Surgery · 26
Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines
2019 · Barbara Rath, Lukas Klameth, et al. · Cancers · 22
PDF
Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer.
2011 · Andreas Pircher, Ernst Ulsperger, et al. · PubMed · 21
Achieving Full-Dose, On-Schedule Administration of ACE Chemotherapy Every 14 Days for the Treatment of Patients with Extensive Small-Cell Lung Cancer
2006 · R. Pirker, E. Ulsperger, et al. · Lung · 21
Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants.
1999 · E Ulsperger, G Hamilton, et al. · International Journal of Oncology · 21
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia—A Retrospective Analysis in 337 Patients
2020 · Klaus Geissler, Eva Jäger, et al. · International Journal of Molecular Sciences · 20
PDF
How to target small cell lung cancer
2015 · Gerhard Hamilton, Barbara Rath, et al. · Oncoscience · 20
PDF
Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines
2019 · Maximilian Hochmair, Barbara Rath, et al. · Investigational New Drugs · 19
PDF
Docetaxel in the treatment of non-small cell lung cancer (NSCLC) -- an observational study focusing on symptom improvement.
2013 · Andreas Pircher, Ines Kristin Wasle, et al. · PubMed · 19
Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgen suppression therapy
1999 · Gerhard Theyer, Alexander D�rer, et al. · The Prostate · 15
Metabolism of camptothecin, a potent topoisomerase I inhibitor, in the isolated perfused rat liver
2000 · Peter Platzer, Theresia Thalhammer, et al. · Cancer Chemotherapy and Pharmacology · 13
The role of surgery in small cell lung cancer
1990 · E. Ulsperger, T. Shields, et al. · Lung Cancer · 12
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia
2021 · Sigrid Machherndl‐Spandl, Eva Jäger, et al. · European Journal Of Haematology · 11
PDF
O-88 Gemcitabine and cisplatin (GC) +/-subsequent maintenance therapy with single-agent gemcitabine in advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized trial of the Central European Cooperative Oncology Group (CECOG)
2003 · Maciel Krzakowski, Miklos Wenczl, et al. · Lung Cancer · 11
Works count: 59
Citation count: 1,329
H-index: 19
I10-index: 28
Year
Topic
Type